Using Central Cancer-Registry Data to Monitor Progress in Early Detection of Breast and Cervical Cancer (Illinois, United States)

Cases of breast and cervical cancer account for almost 40 percent of all cancers diagnosed in Illinois (United States) women. Information on screening rates, however, is not collected routinely for the populations at risk. This paper reports on surveillance indicators designed to identify target pop...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Cancer Causes & Control. - Springer Science + Business Media. - 6(1995), 2, Seite 155-163
1. Verfasser: Howe, Holly L. (VerfasserIn)
Weitere Verfasser: Lehnherr, Melinda, Qualls, Raquel Y.
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 1995
Zugriff auf das übergeordnete Werk:Cancer Causes & Control
Schlagworte:Breast neoplasms Cervical neoplasms Females Race Registries United States Health sciences Behavioral sciences Political science Social sciences
LEADER 01000caa a22002652 4500
001 JST023113359
003 DE-627
005 20240620103128.0
007 cr uuu---uuuuu
008 150324s1995 xx |||||o 00| ||eng c
035 |a (DE-627)JST023113359 
035 |a (JST)3553176 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Howe, Holly L.  |e verfasserin  |4 aut 
245 1 0 |a Using Central Cancer-Registry Data to Monitor Progress in Early Detection of Breast and Cervical Cancer (Illinois, United States) 
264 1 |c 1995 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Cases of breast and cervical cancer account for almost 40 percent of all cancers diagnosed in Illinois (United States) women. Information on screening rates, however, is not collected routinely for the populations at risk. This paper reports on surveillance indicators designed to identify target populations and evaluate programs. All cases of cancers of the breast (n = 38,824, including in situ) and invasive cervix (n = 2,763) with a known stage, among women aged 40 to 74, were identified through the population-based Illinois State Cancer Registry for 1986 to 1992. The proportion of breast cancer cases with in situ disease-stage and cervical cancer cases with a late invasive stage were selected as surveillance indicators. Differences by age and race were evaluated, as were age- and race-specific trends. The data suggest that Black women, aged 40 to 74 years, and White women, aged 65 to 74 years, should be targeted for breast-cancer-screening interventions. All women, aged 40 to 74, should be targeted for enhanced cervical-cancer-screening interventions. Significant trends in in situ breast cancer diagnoses were apparent in all age-race groups, however no significant decline in invasive cervical cancer was found for any age-race group. The indicators identified the age- and race-specific disparities among potential target populations for breast and cervical cancer screening. 
540 |a Copyright 1995 Rapid Communications of Oxford Ltd. 
650 4 |a Breast neoplasms 
650 4 |a Cervical neoplasms 
650 4 |a Females 
650 4 |a Race 
650 4 |a Registries 
650 4 |a United States 
650 4 |a Health sciences  |x Medical conditions  |x Diseases  |x Neoplasia  |x Cancer  |x Cervical cancer 
650 4 |a Behavioral sciences  |x Anthropology  |x Ethnology  |x Ethnic groups  |x Black people 
650 4 |a Health sciences  |x Medical conditions  |x Diseases  |x Neoplasia  |x Cancer 
650 4 |a Health sciences  |x Medical conditions  |x Diseases  |x Breast diseases  |x Breast neoplasms  |x Breast cancer 
650 4 |a Behavioral sciences  |x Anthropology  |x Ethnology  |x Ethnic groups  |x White people 
650 4 |a Health sciences  |x Medical specialties  |x Medicine  |x Internal medicine  |x Oncology  |x Cancer screening 
650 4 |a Political science  |x Government  |x Government agencies  |x Intelligence services  |x Surveillance 
650 4 |a Social sciences  |x Population studies  |x Mortality 
650 4 |a Social sciences  |x Population studies  |x Demography  |x Age groups 
650 4 |a Health sciences  |x Health and wellness  |x Public health  |x Epidemiology  |x Research Papers 
655 4 |a research-article 
700 1 |a Lehnherr, Melinda  |e verfasserin  |4 aut 
700 1 |a Qualls, Raquel Y.  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Cancer Causes & Control  |d Springer Science + Business Media  |g 6(1995), 2, Seite 155-163  |w (DE-627)306324288  |w (DE-600)1496544-6  |x 15737225  |7 nnns 
773 1 8 |g volume:6  |g year:1995  |g number:2  |g pages:155-163 
856 4 0 |u https://www.jstor.org/stable/3553176  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_JST 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_23 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_32 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_63 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_73 
912 |a GBV_ILN_74 
912 |a GBV_ILN_90 
912 |a GBV_ILN_95 
912 |a GBV_ILN_100 
912 |a GBV_ILN_101 
912 |a GBV_ILN_105 
912 |a GBV_ILN_110 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_138 
912 |a GBV_ILN_150 
912 |a GBV_ILN_151 
912 |a GBV_ILN_152 
912 |a GBV_ILN_161 
912 |a GBV_ILN_170 
912 |a GBV_ILN_171 
912 |a GBV_ILN_187 
912 |a GBV_ILN_206 
912 |a GBV_ILN_213 
912 |a GBV_ILN_224 
912 |a GBV_ILN_230 
912 |a GBV_ILN_285 
912 |a GBV_ILN_293 
912 |a GBV_ILN_370 
912 |a GBV_ILN_374 
912 |a GBV_ILN_602 
912 |a GBV_ILN_647 
912 |a GBV_ILN_702 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2004 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2011 
912 |a GBV_ILN_2014 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2020 
912 |a GBV_ILN_2021 
912 |a GBV_ILN_2025 
912 |a GBV_ILN_2026 
912 |a GBV_ILN_2027 
912 |a GBV_ILN_2031 
912 |a GBV_ILN_2034 
912 |a GBV_ILN_2037 
912 |a GBV_ILN_2038 
912 |a GBV_ILN_2039 
912 |a GBV_ILN_2043 
912 |a GBV_ILN_2044 
912 |a GBV_ILN_2048 
912 |a GBV_ILN_2050 
912 |a GBV_ILN_2055 
912 |a GBV_ILN_2056 
912 |a GBV_ILN_2057 
912 |a GBV_ILN_2059 
912 |a GBV_ILN_2061 
912 |a GBV_ILN_2064 
912 |a GBV_ILN_2065 
912 |a GBV_ILN_2068 
912 |a GBV_ILN_2088 
912 |a GBV_ILN_2093 
912 |a GBV_ILN_2106 
912 |a GBV_ILN_2107 
912 |a GBV_ILN_2108 
912 |a GBV_ILN_2110 
912 |a GBV_ILN_2111 
912 |a GBV_ILN_2112 
912 |a GBV_ILN_2113 
912 |a GBV_ILN_2116 
912 |a GBV_ILN_2118 
912 |a GBV_ILN_2119 
912 |a GBV_ILN_2122 
912 |a GBV_ILN_2129 
912 |a GBV_ILN_2143 
912 |a GBV_ILN_2144 
912 |a GBV_ILN_2147 
912 |a GBV_ILN_2148 
912 |a GBV_ILN_2152 
912 |a GBV_ILN_2153 
912 |a GBV_ILN_2158 
912 |a GBV_ILN_2188 
912 |a GBV_ILN_2190 
912 |a GBV_ILN_2193 
912 |a GBV_ILN_2232 
912 |a GBV_ILN_2336 
912 |a GBV_ILN_2446 
912 |a GBV_ILN_2470 
912 |a GBV_ILN_2472 
912 |a GBV_ILN_2507 
912 |a GBV_ILN_2522 
912 |a GBV_ILN_2548 
912 |a GBV_ILN_2808 
912 |a GBV_ILN_2943 
912 |a GBV_ILN_2946 
912 |a GBV_ILN_2949 
912 |a GBV_ILN_2951 
912 |a GBV_ILN_4012 
912 |a GBV_ILN_4035 
912 |a GBV_ILN_4037 
912 |a GBV_ILN_4046 
912 |a GBV_ILN_4112 
912 |a GBV_ILN_4125 
912 |a GBV_ILN_4126 
912 |a GBV_ILN_4242 
912 |a GBV_ILN_4246 
912 |a GBV_ILN_4249 
912 |a GBV_ILN_4251 
912 |a GBV_ILN_4277 
912 |a GBV_ILN_4305 
912 |a GBV_ILN_4306 
912 |a GBV_ILN_4307 
912 |a GBV_ILN_4313 
912 |a GBV_ILN_4322 
912 |a GBV_ILN_4323 
912 |a GBV_ILN_4324 
912 |a GBV_ILN_4325 
912 |a GBV_ILN_4326 
912 |a GBV_ILN_4328 
912 |a GBV_ILN_4333 
912 |a GBV_ILN_4334 
912 |a GBV_ILN_4335 
912 |a GBV_ILN_4336 
912 |a GBV_ILN_4338 
912 |a GBV_ILN_4346 
912 |a GBV_ILN_4367 
912 |a GBV_ILN_4393 
912 |a GBV_ILN_4700 
912 |a GBV_ILN_4753 
951 |a AR 
952 |d 6  |j 1995  |e 2  |h 155-163